| abstract |
The present disclosure relates to one or more individuals selected from compounds of formula (I) and pharmaceutically acceptable salts thereof: [In the formula, The variable groups X, R1, R2, R3, m, n and p are as defined herein]. The present disclosure also relates to methods of making one or more such individuals, and intermediates useful in their preparation, pharmaceutical compositions containing one or more such individuals, the use of one or more such individuals in the manufacture of medicaments, and allergic diseases, autoimmune diseases, It relates to the use of one or more such individuals in the treatment of conditions such as viral diseases and cancer. |